Kyowa Kirin Co., Ltd. (KYKOF)
OTCMKTS · Delayed Price · Currency is USD
17.13
+2.38 (16.14%)
At close: Jul 28, 2025
Kyowa Kirin Market Cap
Kyowa Kirin has a market cap or net worth of $8.67 billion as of September 12, 2025. Its market cap has decreased by -23.50% in one year.
Market Cap
8.67B
Enterprise Value
7.24B
Revenue
3.42B
Ranking
n/a
PE Ratio
32.57
Stock Price
$17.13
Market Cap Chart
Since May 6, 1994, Kyowa Kirin's market cap has increased from 4.24B to 8.67B, an increase of 104.50%. That is a compound annual growth rate of 2.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 8.67B | 12.74% |
| Dec 30, 2024 | 7.69B | -14.89% |
| Dec 29, 2023 | 9.04B | -26.56% |
| Dec 30, 2022 | 12.31B | -15.87% |
| Dec 30, 2021 | 14.63B | -0.02% |
| Dec 30, 2020 | 14.63B | 15.29% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |